Time to compare the OUTCOMES of all vaccinations in use and compare with predictions from clinical trials over the last four decades - AUDIT THE JABS
The investigations and analyses of Pfizer and Moderna C19 mRNA injections for
· Phase 1 and 2 pre-clinical trials
· Phase 3 clinical trials,
· post marketing authorization report to February 2021
· Phase 4 ( surveillance reports due in May 2023?)
· adverse events reported to vaccine safety monitoring systems
represent the most thorough of ALL vaccinations mandated as part of “vaccine schedules” in decades.
How many of the leading and increasing disorders and diseases in the US are a direct result of “vaccines” containing contaminants like mercury and aluminum, failure to monitor and report adverse events, or from “bad batches” or undetected manufacturing and supply chain issues?
Let’s take a quick look at the distressing statistics in the US. Autism and ADHD. Alzheimer’s and Dementia have their own distressing characteristics and so do many other conditions and diseases..
(A primer on the difference between ADHD and Autism is here)
Summary data here: Data & Statistics on Autism Spectrum Disorder | CDC
“About 1 in 44 children has been identified with autism spectrum disorder (ASD) according to estimates from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network.”
“About 1 in 6 (17%) children aged 3–17 years were diagnosed with a developmental disability, as reported by parents, during a study period of 2009-2017. These included autism, attention-deficit/hyperactivity disorder, blindness, and cerebral palsy, among others. ”
In a 2000 study of 8 year olds, autism prevalence was 6.7 per 1,000 (- one in 150). By 2018 prevalence was 23 per 1,000 – more than 3 times higher than in 2000 and equal to one in 44 kids.
A little more detail on the 2018 study of US 8 year olds.
“Overall ASD prevalence per 1,000 children aged 8 years was similar among White, Black, A/PI, and Hispanic children (21.2, 22.3, 22.2, and 22.5, respectively) (Table 3).”
“Among the 3,833 children aged 8 years with ASD who had an evaluation containing an ASD diagnostic statement, the median age at earliest known diagnosis was 50 months (range: 36 months in California to 63 months in Minnesota) (Table 7)..”
Other key facts here:
69+ Autism Statistics, Rates & Prevalence (crossrivertherapy.com)
And here:
51 Autism Statistics: How Many People Have Autism? (discoveryaba.com)
The worst US States have these numbers “The states with the highest prevalence of autism diagnoses are Rhode Island, Maryland, and Florida, all with rates of over 4%.”
Florida’s rate is 4.88%.
Now for ADHD.
Data and Statistics About ADHD | CDC
“The estimated number of children aged 3–17 years ever diagnosed with ADHD, according to a national survey of parents,1 is 6 million (9.8%) using data from 2016-2019. This number includes
3–5 years: 265,000 (2%), 6–11 years 2.4 million (10%). 12–17 years: 3.3 million (13%)
ADHD diagnosis among children aged 3–17 years: State estimates vary from 6% to 16%.”
One in 6 13-17 year olds have ADHD. One in 10 6-11 year olds.
No doubt there are many studies on the State differences.
Cases have almost doubled since 2006. ADHD Throughout the Years | CDC.
What could be causing these large increases in prevalence? Diet, or pollution, maybe climate change or is it – vaccinations?
With these indicators from just two of the most distressing conditions, let’s put the records of clinical trials for all vaccinations under a similar microscope as we have done with C19 mRNA injections.
Crucially, how many clinical trials for mandated “vaccines” actually failed their clinical trials in the same way that Pfizer and Moderna failed theirs. How many were unblinded before the end of the trial, how many were underpowered and how many adverse events were not reported either at the post marketing authorization stage, or for adverse events (like ADHD and Autism) in the years following injections.
In other words, how prevalent has the lack of quality in the approval and monitoring process at the FDA and CDC been going on?
It is time to compare outcomes with predictions from clinical trials.
I suspect that the only valid placebo groups to compare against are those with religious exemptions from vaccines. Like the Church of the First Born, End Time Ministries, Faith Assembly, Faith Tabernacle, First Century Gospel Church, The First Church of Christ, Scientist (Christian Scientist) or maybe amongst the 330,000 Amish people living in the US.
Let’s return to the outcomes of the C19 mRNA injections. Those familiar may want to skip the rest of this post.
Quick point. The following narrative is “C19 mRNA injection” centric. It does not include any reference to available and proven effective treatment protocols for the SARS-COV2 virus or early yo mid-stage C19 disease, involving, for eacmple, Ivermectin and Hydroxychloroquine. Nor does it deal with the false diagnosis of C19 using RT-PCR or RAT testing, or that deaths diagnosed using false testing methods should be assigned to negligent homicide from Remdesivir/Midazolam or failure to diagnose or treat with antibiotics because it was thought these would “interfere” with C19 mRNA injections or the removal of the “will to live” by denying familial support and isolating the elderly.
Let’s take each bullet point at the top of this article in turn. We can leave aside the (absence) of Phase 1 animal trials and the errors and omissions in the Phase 2 clinical trials to determine dosage for use in the Phase 3 clinical trials. Phase 4 is due in the next few months.
· Phase 1 and 2 pre-clinical trials
· Phase 3 clinical trials,
· post marketing authorization report to February 2021
· Phase 4 ( surveillance reports due in May 2023?)
· adverse events reported to vaccine safety monitoring systems
That leaves only the Phase 3 clinical trials!
In Pfizer’s own words.. “The Phase 3 clinical trial was designed to determine if the Pfizer-BioNTech COVID-19 vaccine is safe and effective in preventing COVID-19 disease. This trial began July 27, 2020 and completed enrollment of 46,331 participants in January 2021. On November 18, Pfizer and BioNTech announced that, after conducting the primary efficacy analysis, their mRNA-based COVID-19 vaccine met all of the study’s primary efficacy endpoints.”
There was only one “primary efficacy end point”, that of preventing symptoms of disease, not preventing transmission, hospitalization or death. Using the words “all of the study’s primary efficacy endpoints” is hyperbole and misleading.
Column headings in the table below are Moderna, Pfizer and Astra Zeneca (US).
The UK’s MHRA approved the Pfizer injections for emergency use on 2 December 2020, before the enrolments in clinical trials were completed. The US FDA approved it on the same bases a week or so later.
We know that the Pfizer/BioNTech phase 3 clinical trial was unblinded early. We know that the results of the clinical trial should have resulted in a “FAIL”.
We know that the recovery rate from C19 is in excess of 97%. We know that the infection rate of the general population exceeds 91%. So how did the UK’s MHRA and the FDA approve the Pfizer/BioNTech roll-out, based on the FAILED Pfizer/BioNtech clinical trials?
The sole clinical end point was the prevention of symptoms of C19 disease. These symptoms manifest in Adverse Events – especially “Severe” (life altering) and “Serious” events. Even leaving aside the higher all cause mortality of those injected, there is clear, unmistakable, evidence of SIGNIFICANTLY higher symptoms in the injected group.
Enquiring minds might want to know how on earth there were 1,311 RELATED adverse events out of 21,900 people in the placebo? I repeat – 97% of those with the SARS-COV2 infection, recover after around 10-15 days. The trial, unblinded early, but intended to run for 6 months, should have reflected the recovery rate and the demographics of those recovered. It didn’t.
Note the “poacher turned game keeper” attitude. The company responsible for testing stands to make billions of dollars if it produces a positive report to PASS clinical trials.
I wonder what the under-reporting factor within the trials was. Whistle-blowers have come forward. Brook Jackson was sacked within minutes, after reporting massive clinical trial failures to the FDA - who immediately phoned her employer, breaching all FEDERAL whistle blower protections.
Indeed, Sasha Latypova has shown that the entire authorization and roll-out of the C19 mRNA injections is and was a pantomime run by the US Department of Defence. Injections are a military counter-measure to defeat an enemy – foreign or domestic – all laws, health regulations, parliaments, constitutions, liabilities for crimes committed whilst pursuing military objectives are null and void – martial law, under a state of emergency, dominates. Why this also applies to other countries, other than via “the co-operation of and with allies” during a war, is a mystery.
That’s the Phase 3 clinical trials covered. How about the US post marketing authorization that ran from 11 December 2020 (FDA authorization date) and 28 February 2021.
I will leave the detailed work being done by hundreds of people at the Daily Clout and focus on one key section revealed 50-75 years before the FDA and Pfizer wanted thanks to Aaron Siri and Del Bigtree of the Highwire.
Here is a link to the initial publication of the post-marketing authorization surveillance report.
5.3.6-postmarketing-experience.pdf (phmpt.org)
Page 6 has this “3. RESULTS
“3.1. Safety Database
3.1.1. General Overview
It is estimated that approximately (b) (4) doses of BNT162b2 were shipped worldwide from the receipt of the first temporary authorisation for emergency supply on 01 December 2020 through 28 February 2021.
Cumulatively, through 28 February 2021, there was a total of 42,086 case reports (25,379 medically confirmed and 16,707 non-medically confirmed) containing 158,893 events. Most cases (34,762) were received from United States (13,739), United Kingdom (13,404) Italy (2,578), Germany (1913), France (1506), Portugal (866) and Spain (756); the remaining 7,324 were distributed among 56 other countries.”
Note the redacted number of doses with (b) (4). This report was updated with the number of doses here:
reissue_5.3.6-postmarketing-experience.pdf (phmpt.org)
The number of doses was displayed as 126,212,580. These are doses SHIPPED, not doses administered. Almost all doses were shipped to the EU and US. Check out how many were adinisted in the EU and US.
COVID-19 vaccine doses administered by manufacturer, European Union (ourworldindata.org)
COVID-19 vaccine doses administered by manufacturer, United States (ourworldindata.org)
Total doses ADMINISTERED for EU+US for Pfizer = 67 million compared to the 126 million shipped. Now a few doses outside the EU and US were shipped and administered, but the “first world” received doses before anyone else.
So, the RATES of harm inflicted should not be viewed in the context of the Pfizer numbers of SHIPPED doses, but against the number of ADMINSITERED doses. (Note this issue persists in the form of 277 million unused doses for the US and a whopping 435 million unused doses in the EU).
Before you check out the table below for the rates of harm against 67 million doses administered, what was the Under Reporting Factor (URF) for these reports of adverse events. Estimates of URF’s for the US range from an historical less than 1 report per 100 events in the US (Lazarus Report) to around one in 40 (Rose, Kirsch) to 60 (VAERSinfo) – estimates for Europe indicate around 70 (h/t fellow SubStacker Momo).
Go with 40 and multiply the reports received by this number to adjust for under-reporting.
Around 42,000 serious adverse event reports, 1,200 fatal, NINE THOUSAND FOUR HUNDRED UNKNOWN and the rest not recovered without sequelae.
Multiply by 40 and express as rates for 67 million doses in just 80 days from the date of authorization. Keep in mind that there was a queue to get injected, elderly and infirm to receive toxins first (how bass ackwards is that!).48,000 deaths, 1.6 million adverse event reports and 376,000 “unknown”?
Ok, that’s the Phase 3 clinical trials and the 80 day post marketing authorization reports done, now for the adverse events, since then. (Presumably the adverse event post marketing authorization report has all its deaths and events also reported to the VAERS system?).
There’s more detail here, but I will just post these two summary slides. Multiply what you see by at least 40 to adjust for the URF for the US (use the US only reports to the right) and 70 for the EU. I have contacted the EMA and it has not completed any analysis on URF’s for EU vaccines and injections.
EU Adverse Events – one month lag
Imagine if the short and long term events for all vaccines were analysed and interpreted with the same rigour. How many would still be in the market? None?
Onwards!
Coffee donations welcome << click there!
"Don't... don't do that." - B. Gates to then President Trump when Trump wanted to investigate vaccine safety, prior to the Coof.
Thank you and saving this one to read in full when I have a bit more time/bandwidth.